Pacific Biosciences: Michael Hunkapiller, Susan Barnes
Pacific Biosciences announced that CEO and President Michael Hunkapiller will retire by the end of the year. He plans to remain on the company's board. Hunkapiller served eight years as CEO and oversaw the launch of the Sequel and Sequel II instruments.
Susan Barnes, the firm's CFO and executive VP, will also retire in August after more than a decade with the company.
PacBio said it has already begun searching for their replacements.
Quidel: Jack Schuler
Jack Schuler has retired from Quidel's board, effective June 10, the firm said. Schuler, 79, has been on Quidel's board since February 2006. He was the former president and chief operating officer of Abbott Laboratories.
AACC: Mark Golden
Mark Golden has been appointed the CEO of the American Association for Clinical Chemistry, effective Aug. 17. Prior to joining AACC, he was executive director and CEO of the National Society of Professional Engineers for seven years. AACC had previously said that its current CEO Janet Kreizman would retire from the organization.
For additional recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.